Before revision:  Our results indicate that these drugs could act against SARS-CoV-2 by altering the folding pathway of its receptor ACE2. Ongoing studies are directly evaluating the possibility of repurposing these drugs for the treatment of COVID-19 .
After revision:  Our results indicate that these drugs could act against SARS-CoV-2 (MEX-BC2/2020 strain). One of the selected drugs (Artefenomel) could completely prevent cytopathic effects induced by the presence of the virus, thus showing a promising antiviral activity against SARS-CoV-2 .